Business Description
Fuji Pharma Co Ltd
NAICS : 325412
SIC : 2834
ISIN : JP3816200004
Share Class Description:
TSE:4554: Ordinary SharesCompare
Compare
Traded in other countries / regions
4554.JapanFUP.Germany IPO Date
2011-07-11Description
Fuji Pharma Co Ltd is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 2.8 | |||||
| Interest Coverage | 19.81 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.95 | |||||
| Beneish M-Score | -2.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.5 | |||||
| 3-Year EBITDA Growth Rate | 34.4 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 11.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.28 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 10.33 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.24 | |||||
| 9-Day RSI | 50.89 | |||||
| 14-Day RSI | 58.18 | |||||
| 3-1 Month Momentum % | 1.81 | |||||
| 6-1 Month Momentum % | -13.1 | |||||
| 12-1 Month Momentum % | -23.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.68 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 254.04 | |||||
| Days Sales Outstanding | 134.14 | |||||
| Days Payable | 69.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.79 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| 3-Year Dividend Growth Rate | 13.6 | |||||
| Forward Dividend Yield % | 2.95 | |||||
| 5-Year Yield-on-Cost % | 4.09 | |||||
| Shareholder Yield % | 6.91 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.68 | |||||
| Operating Margin % | 8.42 | |||||
| Net Margin % | 13.32 | |||||
| FCF Margin % | -0.48 | |||||
| ROE % | 14.23 | |||||
| ROA % | 7.13 | |||||
| ROIC % | 3.75 | |||||
| 3-Year ROIIC % | 1.45 | |||||
| ROC (Joel Greenblatt) % | 18.34 | |||||
| ROCE % | 15.44 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.01 | |||||
| Forward PE Ratio | 10.57 | |||||
| PE Ratio without NRI | 13.05 | |||||
| Shiller PE Ratio | 12.98 | |||||
| PEG Ratio | 0.61 | |||||
| PS Ratio | 0.8 | |||||
| PB Ratio | 0.81 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Operating-Cash-Flow | 8.9 | |||||
| EV-to-EBIT | 7.29 | |||||
| EV-to-EBITDA | 5.91 | |||||
| EV-to-Revenue | 1.33 | |||||
| EV-to-FCF | -282.14 | |||||
| Price-to-GF-Value | 1.06 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Price-to-DCF (Earnings Based) | 0.8 | |||||
| Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.52 | |||||
| Price-to-Graham-Number | 0.81 | |||||
| Earnings Yield (Greenblatt) % | 13.73 | |||||
| FCF Yield % | -0.6 | |||||
| Forward Rate of Return (Yacktman) % | 16.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fuji Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 46,138 | ||
| EPS (TTM) (円) | 252.85 | ||
| Beta | 0.43 | ||
| 3-Year Sharpe Ratio | 0.57 | ||
| 3-Year Sortino Ratio | 1.36 | ||
| Volatility % | 34.48 | ||
| 14-Day RSI | 58.18 | ||
| 14-Day ATR (円) | 40.509683 | ||
| 20-Day SMA (円) | 1500.45 | ||
| 12-1 Month Momentum % | -23.49 | ||
| 52-Week Range (円) | 1089 - 2060 | ||
| Shares Outstanding (Mil) | 24.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fuji Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fuji Pharma Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fuji Pharma Co Ltd Frequently Asked Questions
What is Fuji Pharma Co Ltd(TSE:4554)'s stock price today?
The current price of TSE:4554 is 円1525.00. The 52 week high of TSE:4554 is 円2060.00 and 52 week low is 円1089.00.
When is next earnings date of Fuji Pharma Co Ltd(TSE:4554)?
The next earnings date of Fuji Pharma Co Ltd(TSE:4554) is .
Does Fuji Pharma Co Ltd(TSE:4554) pay dividends? If so, how much?
The Dividend Yield %  of Fuji Pharma Co Ltd(TSE:4554) is 2.79% (As of Today), Highest Dividend Payout Ratio of Fuji Pharma Co Ltd(TSE:4554) was 0.42. The lowest was 0.21. And the median was 0.3. The  Forward Dividend Yield % of Fuji Pharma Co Ltd(TSE:4554) is 2.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers